Evidence map›Paper›PMID 41298504›Full record

ArticleNature communications2025

Staphylococcus aureus induces Gasdermin A-dependent keratinocyte pyroptosis.

Doris L LaRock, Jacob D Sherman, Claire Qu, William Ngai, Timothy D Read, Martin J McGavin, Christopher N LaRock

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Doris L LaRockDepartment of Microbiology and Immunology, Emory School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-2661-6853
Jacob D ShermanMicrobiology and Molecular Genetics Graduate Program, Emory University, Atlanta, GA, USA.
Claire QuDepartment of Microbiology and Immunology, Emory School of Medicine, Atlanta, GA, USA.
William NgaiDepartment of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.
Timothy D ReadDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-8966-9680
Martin J McGavinDepartment of Microbiology and Immunology, University of Western Ontario, London, ON, Canada.ORCID http://orcid.org/0000-0001-5955-0689
Christopher N LaRockDepartment of Microbiology and Immunology, Emory School of Medicine, Atlanta, GA, USA. christopher.larock@emory.edu.ORCID http://orcid.org/0000-0003-3035-5331

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Genomics of S. Aureus Colonization after Initial and Recurrent Skin Infections and the Impact of AntibioticsR01AI139188 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID, MICHAEL ZDENEK · 2018 to 2022
$3.8M
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)R01AI158452 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Michael Zdenek David · 2022 to 2026
$3.5M
Antimicrobial Resistance and Therapeutic Discovery Training ProgramT32AI106699 · NIAID · EMORY UNIVERSITY · PI Graeme L Conn, Joanna B Goldberg · 2014 to 2026
$2.7M
Proteolytic regulation of the Streptococcus pyogenes cell surfaceR01AI153071 · NIAID · EMORY UNIVERSITY · PI LAROCK, CHRISTOPHER N · 2021 to 2025
$1.9M
GSDMA roles in skin innate immune defenseR01AI180089 · NIAID · EMORY UNIVERSITY · PI Christopher N LaRock · 2024 to 2026
$1.8M
Burroughs Wellcome Fund (BWF) Investigator in the Pathogenesis of Infectious DiseaseGouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-463397NCATS NIH HHS UL1 TR002378NIAID NIH HHS R01 AI139188NIAID NIH HHS R01 AI153071NIAID NIH HHS R01 AI158452NIAID NIH HHS R01 AI180089NIAID NIH HHS T32 AI106699U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI106699U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI139188U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI153071U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI158452
6 · The paper itself

Abstract

Staphylococcus aureus is a common colonizer of human skin, which, despite its ubiquitous nature, has a high virulence potential. Tolerating microbes in health but responding effectively to pathogens presents a challenge to the barrier tissues. Here, we examined the interaction of S. aureus with skin keratinocytes to study this early step of pathogenesis and pathogen discrimination. During infection, the S. aureus protease Staphopain A (ScpA) cleaves inert Gasdermin A (GSDMA). This releases an active N-terminal fragment similar to that formed by host protease regulators of other gasdermins family members. The resulting cell death by pyroptosis allows keratinocytes to deprive invasive S. aureus of an intracellular niche. These data support a model of GSDMA as an autonomous sensor of pathogenicity, in contrast to the conventional regulation of other gasdermins, which have dedicated host cell pathways. Gasdermins abundant in other tissues may have similar functions in host defense for the threat assessment of a microbe.

Indexed as

KeratinocytesPyroptosisStaphylococcus aureusAnimalsBacterial ProteinsGasderminsHost-Pathogen InteractionsHumansMicePhosphate-Binding ProteinsSkinStaphylococcal InfectionsBacterial ProteinsGasderminsGSDMA protein, humanPhosphate-Binding Proteins

Identifiers

PMID41298504
PMCPMC12658218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.